P16 Expression in Human Breast Carcinoma and its Relationship to Clinicopathological Parameters

BACKGROUND: p16 is a cyclin-dependent kinase inhibitor and a cardinal regulator of the cell cycle. The relationship between p16 overexpression and poor prognosis of breast cancer has been reported in some studies. This study aimed to evaluate p16 expression in breast cancer in comparison to normal b...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadizadeh, Fereshteh, Nasri, Farnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410420/
https://www.ncbi.nlm.nih.gov/pubmed/37564443
http://dx.doi.org/10.4103/abr.abr_180_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410420/
https://www.ncbi.nlm.nih.gov/pubmed/37564443
http://dx.doi.org/10.4103/abr.abr_180_22

Ejemplares similares